No Data
No Data
Creo Medical Announces Annual Report and AGM Date
Creo Medical Group (LON:CREO) Shareholders Have Endured a 83% Loss From Investing in the Stock Three Years Ago
Creo Medical Reports Strong Revenue Growth
Creo: Financial results briefing materials for the fiscal year ending 2024/3
Creo Medical Group Appoints New Chair
British medical device company Creo Medical Group (CREO.L) said Monday it appointed Kevin Crofton as its new chair, with effect from July 1. Crofton, who most recently was chief executive of Swiss-lis
Toyota and others announced stock buybacks on 5/8
The stocks that announced share acquisition quota settings on 5/8 (Wednesday) are as follows <7203>Toyota 410 million shares (3.0%) 1 trillion yen (24/5/9-25/4/30) <9101>Yusen 35 million shares (7.6%) 100 billion yen (24/5/9-25/4/30) <8591>ORIX 40 million shares (3.5%) 50 billion yen (24/5/15-25/3/31) <9532>large gas 150
No Data